Literature DB >> 32174302

Clinical outcomes in chronic intervillositis of unknown etiology.

M Bos1, E T M S Harris-Mostert2, L E van der Meeren3, J J Baelde2, D J Williams4, P G J Nikkels3, K W M Bloemenkamp5, M L P van der Hoorn6.   

Abstract

INTRODUCTION: Chronic intervillositis of unknown etiology (CIUE) is a histopathological lesion of the placenta that is frequently accompanied by unfavourable pregnancy outcomes, e.g. miscarriage, fetal growth restriction (FGR) and intrauterine fetal death. Earlier described case series and cohorts have been based on diverse diagnostic criteria of CIUE. To improve our understanding of clinical outcomes associated with CIUE, we report the obstetric and perinatal outcomes in a cohort based on the recently described diagnostic criteria.
METHODS: CIUE is defined as an infiltrate occupying 5% or more of the intervillous space with approximately 80% of mononuclear cells positive for CD68 in the absence of an infection. Thirty-eight cases were included. Also previous and subsequent pregnancies were described.
RESULTS: Pregnancies accompanied by CIUE frequently resulted in FGR (51.6%) and pre-term birth (55.3%). Twenty-nine out of 38 pregnancies (76.3%) with CIUE resulted in a living baby. Women with CIUE frequently have had a miscarriage (16/38; 42%). Four-teen subsequent pregnancies in 8 women resulted in 2 miscarriages, 2 terminations of pregnancy for FGR, 1 early neonatal death and 9 living babies (9/14; 64.3%). Histopathologically confirmed CIUE recurred in 5 out of 10 subsequent pregnancies. Two pregnancies with recurrent CIUE were terminated, one pregnancy ended in a late miscarriage and another resulted in term birth complicated by FGR. Recurrent CIUE can also be accompanied by an uncomplicated pregnancy (1/5; 20%).
CONCLUSION: This study provides additional insight into the clinical phenotype of CIUE and emphasises the need for further research to understand the pathophysiology behind different pregnancy outcomes in CIUE.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32174302     DOI: 10.1016/j.placenta.2020.01.001

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  9 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

2.  SARS-CoV-2 infection of the placenta.

Authors:  Hillary Hosier; Shelli F Farhadian; Raffaella A Morotti; Uma Deshmukh; Alice Lu-Culligan; Katherine H Campbell; Yuki Yasumoto; Chantal Bf Vogels; Arnau Casanovas-Massana; Pavithra Vijayakumar; Bertie Geng; Camila D Odio; John Fournier; Anderson F Brito; Joseph R Fauver; Feimei Liu; Tara Alpert; Reshef Tal; Klara Szigeti-Buck; Sudhir Perincheri; Christopher Larsen; Aileen M Gariepy; Gabriela Aguilar; Kristen L Fardelmann; Malini Harigopal; Hugh S Taylor; Christian M Pettker; Anne L Wyllie; Charles Dela Cruz; Aaron M Ring; Nathan D Grubaugh; Albert I Ko; Tamas L Horvath; Akiko Iwasaki; Uma M Reddy; Heather S Lipkind
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.

Authors:  Henning Feist; Simin Bajwa; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2021-10-24       Impact factor: 2.493

4.  One-Sided Chronic Intervillositis of Unknown Etiology in Dizygotic Twins: A Description of 3 Cases.

Authors:  Lotte E van der Meeren; Juliette Krop; Kyra L Dijkstra; Kitty W M Bloemenkamp; Emily F Cornish; Peter G J Nikkels; Marie-Louise P van der Hoorn; Manon Bos
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 5.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 6.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

7.  Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis.

Authors:  Chloe A Brady; Charlotte Williams; Gauri Batra; Elaine Church; Clare L Tower; Ian P Crocker; Alexander E P Heazell
Journal:  Front Med (Lausanne)       Date:  2021-10-18

8.  Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.

Authors:  Laurel Moar; Chloe Simela; Surabhi Nanda; Andreas Marnerides; Mudher Al-Adnani; Catherine Nelson-Piercy; Kypros H Nicolaides; Panicos Shangaris
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

Review 9.  Histopathological Features of SARS-CoV-2 in Extrapulmonary Organ Infection: A Systematic Review of Literature.

Authors:  Diana Torge; Sara Bernardi; Mauro Arcangeli; Serena Bianchi
Journal:  Pathogens       Date:  2022-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.